Reportable Food Registry Draft Guidance Published for Comment by FDA
Posted on: Tuesday, 16 June 2009, 10:17 CDT
The RFR requires a responsible party to file a report through an FDA internet portal when there is reason to believe that an adulterated food (other than infant formula) will cause serious adverse health consequences or death to humans or animals. "Responsible party" is defined as the person who submits the registration information to FDA for a food facility that manufactures, processes, packs, or holds food for human or animal consumption in
- Who must submit RFR reports of adulterated foods to FDA;
- How, when and where RFR reports may be submitted;
- What information the RFR reports must include; and
- What steps must be taken to notify others in the supply chain of the adulterated food.
The Congressional intent for the RFR is to provide a reliable mechanism to track patterns of adulteration in food in order to support efforts by the FDA to target limited inspection resources to protect the public health. The notice announcing the availability of the draft guidance was published in the Federal Register on
Interested parties have 45 days from the date of publication to submit comments to FDA. Submit written comments on the draft guidance to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
SOURCE U.S. Food and Drug Administration
Source: PR Newswire
Related Articles
- FDA issues draft guidance to industry
- FDA Issues Draft Guidance on Risk Evaluation and Mitigation Strategies
- Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine)
- Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer
- Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
- Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, With U.S. Food and Drug Administration
- Chemical Heritage Foundation (CHF) and the Food and Drug Administration (FDA) Will Cosponsor FDA Centennial Conference at CHF on Tuesday, 16 May 2006
- FDA Releases Draft Guidance on 'Whole Grain'
- U.S. Food and Drug Administration (FDA) Approves BARACLUDE(TM) (Entecavir) for Treatment of Chronic Hepatitis B
User Comments (0)

RSS Feeds